How MedTech Innovators Can Win Payer Coverage Outside Heart Failure, Cancer, and Diabetes

Think your device won’t get payer traction because it’s outside the “big three”? This article breaks down how MedTech companies targeting niche patient populations can still win with U.S. payers by aligning with quality metrics, cost savings, and equity priorities.